Cellular and network mechanisms of epilepsy and neuromodulation summary epilepsy is the world's most common, serious brain disorder, affecting nearly 50 million people worldwide, and accounting for 1%…

Active Project Grant Awarded Last action

Award ID
R01NS139524
Recipient
Awarding agency
Obligated
$1,304,865

Award facts

Completion date 29% complete
Place of performance
Boston, MA 02215, USA

Award details come from USAspending.gov.

Description

Cellular and network mechanisms of epilepsy and neuromodulation summary epilepsy is the world's most common, serious brain disorder, affecting nearly 50 million people worldwide, and accounting for 1% of the global burden of disease. Seizures occur sporadically and paroxysmally in epilepsy and several interictal biomarkers that are present between seizures have been identified to aid in management. Three major interictal biomarkers for seizure risk have been identified, including epileptiform discharges (SPIKES), high- frequency oscillations (RIPPLES) and their CO-occurrence known as spike RIPPLES. We and others have demonstrated that spike RIPPLES in human scalp EEG and stereotactically placed intracranial EEG recordings are the most specific biomarkers to isolate epileptogenic cortex and predict seizure risk. While clinically significant, the neural mechanisms of this epilepsy biomarker remains unknown, and its relationship to seizure generation is unclear. Further, neuromodulation through electrical stimulation is a rapidly expanding and promising treatment option for patients with drug-resistant refractory epilepsy, but the lack of understanding of the neuronal mechanisms has prevented a principled approach in identifying optimal stimulation parameters for consistent clinical response. To address these challenges, we formed an interdisciplinary team with expertise in epilepsy, human neurophysiology, neurostimulation, animal experiments, modeling, and statistics. We will use cutting- edge cellular membrane voltage imaging that we recently pioneered, in conjunction with traditional optogenetics and local field potential recordings, to probe the cellular and network mechanisms of spike RIPPLES and seizures in cortical epilepsy mouse models. Further, we will examine the real-time neuronal impact of clinical electrical stimulation parameters across frequencies and durations on this epilepsy biomarker and seizure, using cellular voltage imaging, free of electrical stimulation artifacts, and compare the impact of stimulation delivered locally at the cortical epileptogenic zone versus at a thalamic "hub" within the epileptic network. At the completion of the study, we hope to elucidate the neuronal mechanisms underlying epileptic activity, reveal insights on how spike RIPPLES relate to seizure, and gain progress towards a principled approach to neurostimulation with an ultimate goal of improving care for patients with epilepsy.

Transactions

Action Obligated Date
Amendment $646,907
Original award $657,958

Subawards

Subrecipient Amount Awarded
Kennedy Krieger Institute, Inc. Dr. Chu and her team will support investigators at Boston University in developing and validating rodent models of epilepsy, analyzing and interpreting rodent… $224,303

Quick answers

Who received award R01NS139524?

R01NS139524 was awarded to Trustees Of Boston University by National Institute of Neurological Disorders and Stroke (National Institutes of Health) on June 1, 2025.

How much is award R01NS139524 worth?

$1,304,865 has been obligated on R01NS139524.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award